GENE ONLINE|News &
Opinion
Blog

2025-04-29|

STAT+: Tariffs are hitting surgical robots and pacemakers, but device companies aren’t sweating it, yet

by Mark Chiang
Share To

NEWSFLASH

**Title: Medical Device Companies Navigate Tariffs on Surgical Robots and Pacemakers**

Medical device companies are facing tariffs imposed by the U.S. government on products such as surgical robots and pacemakers, but industry leaders report minimal financial impact so far. Despite the added costs stemming from President Trump’s trade policies targeting imports from China, these companies have maintained profitability through high profit margins and strategic measures to mitigate tariff effects.

Industry representatives indicate that many medical device manufacturers are employing tactics such as lobbying for exemptions and adjusting supply chains to offset potential losses. These efforts have allowed them to continue operations without significant disruptions or price increases for consumers at this time. While tariffs remain a concern, the sector’s ability to adapt has kept financial strain at bay in the short term.

Newsflash | Powered by GeneOnline AI

Source: https://www.statnews.com/2025/04/28/trump-tariffs-china-medical-device-surgical-robots-lobbying-exemptions/?utm_campaign=rss

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
Dividend Exchange Rate for Q3 2025 Announced by DEC on March 12, 2026
2026-03-12
NewHydrogen Files International Patent Application for ThermoLoop Technology to Enhance Hydrogen Production Efficiency
2026-03-12
BioGene Therapeutics Inc. Appoints Raj S. Pruthi as Director
2026-03-12
Scroll to Top